CABA

Cabaletta Bio (CABA)

Cabaletta Bio Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:CABA

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/15	20:53	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:CABA	Cabaletta Bio Inc
2024/05/15	20:04	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CABA	Cabaletta Bio Inc
2024/05/15	20:00	GlobeNewswire Inc.	Cabaletta Bio Reports First Quarter 2024 Financial Results and Provides Business Update	NASDAQ:CABA	Cabaletta Bio Inc
2024/05/13	21:00	GlobeNewswire Inc.	Cabaletta Bio to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ	NASDAQ:CABA	Cabaletta Bio Inc
2024/03/21	20:00	GlobeNewswire Inc.	Cabaletta Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update	NASDAQ:CABA	Cabaletta Bio Inc
2024/03/20	20:00	GlobeNewswire Inc.	Cabaletta Bio Announces FDA Granted Orphan Drug Designation to CABA-201 for Treatment of Systemic Sclerosis	NASDAQ:CABA	Cabaletta Bio Inc
2024/03/05	07:50	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CABA	Cabaletta Bio Inc
2024/03/05	07:45	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CABA	Cabaletta Bio Inc
2024/03/05	07:36	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CABA	Cabaletta Bio Inc
2024/03/05	07:36	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CABA	Cabaletta Bio Inc
2024/03/05	07:28	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CABA	Cabaletta Bio Inc
2024/02/27	22:00	GlobeNewswire Inc.	Cabaletta Bio to Participate in Upcoming Investor Conferences in March	NASDAQ:CABA	Cabaletta Bio Inc
2024/02/14	23:20	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:CABA	Cabaletta Bio Inc
2024/02/14	08:47	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:CABA	Cabaletta Bio Inc
2024/02/02	06:36	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CABA	Cabaletta Bio Inc
2024/02/02	06:30	GlobeNewswire Inc.	Cabaletta Bio Announces FDA Granted Orphan Drug Designation to CABA-201 for Treatment of Myositis	NASDAQ:CABA	Cabaletta Bio Inc
2024/01/31	22:00	GlobeNewswire Inc.	Cabaletta Bio to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference	NASDAQ:CABA	Cabaletta Bio Inc
2024/01/20	08:30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CABA	Cabaletta Bio Inc
2024/01/08	21:11	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CABA	Cabaletta Bio Inc
2024/01/08	21:00	GlobeNewswire Inc.	Cabaletta Bio Receives Additional FDA Fast Track Designations for CABA-201 in Dermatomyositis and Systemic Sclerosis	NASDAQ:CABA	Cabaletta Bio Inc
2024/01/02	22:00	GlobeNewswire Inc.	Cabaletta Bio to Present at the 42nd Annual J.P. Morgan Healthcare Conference	NASDAQ:CABA	Cabaletta Bio Inc
2023/12/20	10:37	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CABA	Cabaletta Bio Inc
2023/11/29	20:18	IH Market News	Amazon Unveils Innovative Services, Okta Discloses Data Breach, Textron Plans 2% Global Workforce Reduction, and More	NASDAQ:CABA	Cabaletta Bio Inc
2023/11/29	06:30	GlobeNewswire Inc.	Cabaletta Bio to Participate in the 6th Annual Evercore ISI HealthCONx Conference	NASDAQ:CABA	Cabaletta Bio Inc
2023/11/29	04:59	Dow Jones News	Cabaletta Bio Down as FDA Looks Into Issues With Several Companies' Approved CAR T Drugs	NASDAQ:CABA	Cabaletta Bio Inc
2023/11/22	06:30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CABA	Cabaletta Bio Inc
2023/11/21	06:16	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:CABA	Cabaletta Bio Inc
2023/11/09	21:24	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:CABA	Cabaletta Bio Inc
2023/11/09	21:12	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CABA	Cabaletta Bio Inc
2023/11/09	21:00	GlobeNewswire Inc.	Cabaletta Bio Reports Third Quarter 2023 Financial Results and Provides Business Update	NASDAQ:CABA	Cabaletta Bio Inc